Autologous stem cell transplantation and IgM amyloidosis

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1006-1012

  Valente, Maria ^a   Roy, Vivek ^a   Lacy, Martha ^b   Dispenzieri, Angela ^b   Gertz, Morie ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Amyloidosis; Chemotherapy; IgM; Transplantation

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; CALCIUM; CHLORAMBUCIL; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; MELPHALAN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ACINETOBACTER; ACUTE KIDNEY FAILURE; ADULT; AGED; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LIVER DISEASE; LIVER FAILURE; MALE; MEDICAL DECISION MAKING; MORTALITY; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STREPTOCOCCUS; TREATMENT OUTCOME; UNITED STATES;

AGED; AMYLOIDOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 33746272912     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600572624     Document Type: Article

References (19)

1. Gertz, M and Kyle, R. (2003) Amyloidosis with IgM monoclonal gammopathies Semin Oncol, 2, pp. 325-328.
2. Gertz, M and Kyle, R and Noel, P. (1993) Primary systemic amyloidosis: A rare complication of immunoglobulin M monoclonal gammopathies and waldenstrom's macroglobulinemia J Clin Oncol, 5, pp. 914-920.
3. Comenzo, R and Gertz, M. (2002) Autologous stem cell transplantation for primary systemic amyloidosis Blood, 99, pp. 4276-4282.
4. Kyle, R and Bayrd, E. (1975) Amyloidosis: Review of 236 cases Medicine, 54, pp. 271-299.
5. Kyle, R and Greipp, P. (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases Mayo Clin Proc, 58, pp. 665-683.
6. Kyle, R and Gertz, M. (1995) Primary systemic amyloidosis: Clinical and laboratory features in 474 cases Semin Hematol, 32, pp. 45-59.
7. Gertz, M and Lacy, M and Dispenzieri, A. (2004) Therapy for immunoglobulin light chain amyloidosis: The new and the old Blood Rev, 18, pp. 17-37.
8. Kyle, R and Gertz, M and Greipp, P and Witzig, T and Lust, J and Lacy, M and et al. (1997) A trial of three regimens for primary systemic amyloidosis: Colchicines alone, melphalan and prednisone, and melphalan, prednisone and colchicines N Engl J Med, 336, pp. 1202-1207.
9. Gertz, M and Kyle, R and Greipp, P. (1991) Response rates and survival in primary systemic amyloidosis Blood, 77, pp. 257-262.
10. Palladini, G and Perfetti, V and Obici, L and Caccialanza, R and Semino, A and Adami, F and et al. (2004) Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation Blood, 103, pp. 2936-2938.
11. Attal, M and Harousseau, J and Stoppa, A and Sotto, J and Fuzibet, J and Rossi, J and et al. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med, 335, pp. 91-97.
12. Comenzo, R and Vosburgh, E and Simms, R and Bergethon, P and Sarnecki, D and Finn, K and et al. (1996) Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: One-year follow-up in five patients Blood, 88, pp. 2801-2806.
13. Gono, T and Matsuda, M and Shimojima, Y and Ishii, W and Yamamoto, K and Koyama, J and et al. (2004) IgM AL amyloidosis due to a B cell lymphoproliferative disorder: Efficacy of high-dose melphalan followed by autologous stem cell transplantation Amyloid, 11, pp. 130-135.
14. Skinner, J and Sanchorawala, V and Seldin, D and Dember, L and Falk, R and Berk, J and et al. (2004) High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study Ann Intern Med, 140, pp. 85-93.
15. Seldin, D and Anderson, J and Sanchorawala, V and Malek, K and Wright, D and Quillen, K and et al. (2004) Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation Blood, 104, pp. 1888-1893.
16. Jantunen, E and Siitonen, T and Putkonen, M and Koivunen, E and Juvonen, E and Nousiainen, T and et al. (2004) Autologous stem cell transplantation in patients with primary amyloidosis: A nation-wide survey Leuk Lymphoma, 45, pp. 2485-2489.
17. Dispenzieri, A and Kyle, R and Lacy, M and Therneau, T and Larson, D and Plevak, M and et al. (2004) Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: A case-control study Blood, 103, pp. 3960-3963.
18. Gertz, M and Lacy, M and Dispenzieri, A and Gastineau, D and Chen, M and Ansell, S and et al. (2002) Stem cell transplantation for the management of primary systemic amyloidosis Am J Med, 113, pp. 549-555.
19. Gertz, M and Comenzo, R and Falk, R and Fermand, J and Hazenberg, B and Hawkins, P and et al. (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th international symposium on amyloid and amyloidosis Am J Hematol, 79, pp. 319-328.